Date Insider Type Main position Quantity % Market Cap.
20-08-27Tax

Executive/Senior Manager

281 0.0002%
20-08-27Tax

General Counsel

997 0.0007%
20-08-27Tax

Chief Financial Officer

256 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%-10.00% - - 3.6M
-1.18%-6.13%+47.88%+155.24% 1,028B
-0.20%-3.61%+63.62%+59.61% 611B
+1.78%-2.35%+32.41%+83.04% 432B
+1.18%-1.22%+29.73%+23.34% 323B
-0.44%-3.16%+26.92%+43.57% 277B
+1.53%-11.76%+19.72%+23.20% 257B
+3.21%+2.32%-23.66%-38.31% 217B
+1.05%-2.98%+22.06%+56.70% 192B
+1.63%-3.35%+20.36%+69.42% 161B
Average +0.92%-5.24%+26.56%+52.87% 388.7B
Weighted average by Cap. +0.36%-5.52%+36.20%+77.54%
Logo Akorn, Inc.
Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.
Employees
-
  1. Stock Market
  2. Stocks
  3. AKRXQ Stock